— Item 12 of 16 = y Mark <I e a i @ al

= : L
Question Id: 11590 Praras Next FullScreen Tutorial__—_Lab Values

A 43-year-old man comes to the office after a recent hospitalization for Pneumocystis
pneumonia. The patient is taking trimethoprim-sulfamethoxazole and says that his pulmonary
symptoms are better. He has a history of HIV and was on highly active antiretroviral therapy
until self-discontinuing treatment 2 years ago. On physical examination, the patient appears to
: be in no acute distress. BMI is 20 kg/m. A few crackles are heard at the lung bases. His
most recent CD4 count is 122/mms. After discussing medical compliance and the need to

: resume antiretroviral therapy, HIV genotyping assay is performed. Additional testing for HLA-
as B*57:01 yields positive results. Which of the following medications is contraindicated in this
patient due to the risk of a potentially fatal hypersensitivity reaction?

SY A. Abacavir (52%)
B. Darunavir (6%)
C. Efavirenz (18%)
D. Emtricitabine (12%)

E. Nevirapine (9%)

Waiting for www.uworl

Notes

Calculator

e @A 8

Reverse Color _Text Zoom Settings

Activate Windows

End Block
